Found 73 matching trials
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
Live Vaccines and Innate Immune Training in COPD. PHASE4 A randomized, single-blinded clinical pilot study to assess whether vaccina...
Show More Location
Department of Internal Medicine, Section of Respiratory Medicine
Learn More & Join Trial
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age PHASE3 The purpose of this study is to evaluate the immunogenicity and safety of G...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety Study of ProQuad® rHA in Infants (V221-037) PHASE3 Primary objective: To describe the safety profile of a second dose of ProQu...
Show More Location
Multiple Locations
Learn More & Join Trial
The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine PHASE4 The purpose of this study is to evaluate the immunogenicity and safety of R...
Show More Location
Yuecheng Center for Disease Control and Prevention
Learn More & Join Trial
V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) PHASE3 The study is being conducted to demonstrate that V221 may be administered c...
Show More Location
Multiple Locations
Learn More & Join Trial
Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age PHASE3 The purpose of this study is to evaluate consistency in terms of the immune...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children PHASE3 The purpose of this study is to assess the immunogenicity and safety of GSK...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) PHASE3 The purpose of this clinical study is to evaluate the safety and immunogeni...
Show More Location
Hvidovre Hospital ( Site 0003)
Learn More & Join Trial
Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis PHASE3 The objective of this randomized clinical trial is to test whether administ...
Show More Location
Clinical and Translational Research Center
Learn More & Join Trial